Portfolio company
Everimmune
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops live biotherapeutic products and diagnostic tools for cancer patients to restore their response to immunotherapy treatments.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Laguna Bio
This company develops engineered microbial therapies that activate the immune system to treat cancer patients.
Vivere Oncotherapies
This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.
Neobe
The company develops engineered microbial biotherapeutics designed to disrupt the microenvironment of solid tumours for cancer patients receiving immunotherapy.
Bactheravax
This company develops therapeutic vaccines targeting tumour-associated bacteria to improve treatment sensitivity and immune responses for patients with colorectal and other cancers.
MRM Health
This biopharmaceutical company develops microbiome-based live biotherapeutic products for patients with chronic inflammatory diseases and immune-oncology conditions.
eMMUNITY
This biotechnology company develops personalised cancer vaccines and diagnostic tools to identify the most effective treatments for oncology patients.
mbiomics
This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.
Enterome
This biopharmaceutical company develops microbiome-derived immunotherapies for patients with solid and liquid cancers, including non-Hodgkin lymphoma, and inflammatory diseases.
